Statements (36)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
venture capital firm
|
| gptkbp:employeeCount |
51-200
|
| gptkbp:focus |
healthcare
technology biotechnology |
| gptkbp:founded |
1980
|
| gptkbp:founder |
gptkb:David_B._Mott
|
| gptkbp:headquarters |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Atlas Venture
|
| gptkbp:investmentFocus |
software
medical devices collaborative partnerships therapeutics digital health diagnostics seed funding early stage venture funding company building healthcare_IT |
| gptkbp:notableEvent |
gptkb:AstraZeneca
gptkb:Syndax_Pharmaceuticals gptkb:Zynerba_Pharmaceuticals gptkb:Sierra_Oncology Aileron Therapeutics |
| gptkbp:partnerships |
gptkb:Duke_University
gptkb:Harvard_University gptkb:Johns_Hopkins_University gptkb:Stanford_University gptkb:MIT |
| gptkbp:portfolioCompany |
gptkb:AstraZeneca
gptkb:Syndax_Pharmaceuticals gptkb:Zynerba_Pharmaceuticals gptkb:Sierra_Oncology Aileron Therapeutics |
| gptkbp:website |
www.atlasventure.com
|